Código QR (código de barras bidimensional)

Development of Focal Nodular Hyperplasia Post Dual Anti-HER2 Blockade with Pertuzumab and Trastuzumab in a Patient with Breast Cancer: A Case Report and Literature Review

Targeted therapies like trastuzumab and pertuzumab have substantially improved outcomes in HER2-positive breast cancer with rare reports of significant adverse events. One such rarely reported adverse event is focal nodular hyperplasia (FNH), an uncommon hepatic condition, typically benign and asymp...

ver descrição completa

Na minha lista:
Principais autores: Udip Maheshwari, Disha Morzaria, Vashishth Maniar, Ritu Dave, Nikhat Shaikh, Bhavin Jankharia, Karthik Ganesan
Formato: Artigo
Idioma:Inglês
Publicado em: Thieme Medical and Scientific Publishers Pvt. Ltd.
coleção:Indian Journal of Medical and Paediatric Oncology
Assuntos:
breast cancer
dual anti-HER2 blockade
focal nodular hyperplasia
pertuzumab
trastuzumab
Acesso em linha:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados